6-Month Subcutaneous Leuprolide Acetate Effectively Suppresses Clinical Signs of Puberty in Children With Central Precocious Puberty

Objective: Gonadotropin-releasing hormone (GnRH) agonists, such as intramuscular leuprolide acetate, triptorelin and the subcutaneous histrelin implant, are standard treatment for central precocious puberty (CPP). Implants require surgery and sometimes anesthesia, while frequent intramuscular inject...

Descripción completa

Detalles Bibliográficos
Autores principales: Eugster, Erica A, Atkinson, Stuart, Boldt-Houle, Deborah, Miller, Bradley Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090639/
http://dx.doi.org/10.1210/jendso/bvab048.1356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090639/
http://dx.doi.org/10.1210/jendso/bvab048.1356

Ejemplares similares